
MDS Papers
Groups at MDS publish and release a variety of papers to advance the field of Movement Disorders.
Featured
Key papers from the Scientific Issues Committee
Evidence-Based Medicine Reviews:
White paper: Research Priorities for Gait and Balance Disturbances in Parkinson’s Disease (2022)
All MDS Papers
These papers represent the work of various MDS Task Forces, Committees, and Study Groups to address areas in the field of Movement Disorders. Their results and efforts further the clinical and scientific mission of the Society. They include position papers, critiques, and recommendations on rating scales, guidelines, and reports.
![]()
MDS PD e-Diary: A New Patient-Centered Digital Tool in Development for People with Parkinson's Disease
December 2025- Care Models
- Parkinson Disease/Hypokinetic Movement Disorders
- Published paper
![]()
Complementary and Integrative Medicine for the Treatment of Tourette's Syndrome
December 2025- Hyperkinetic Movement Disorders
- Therapies-Other
- Complementary and Alternative Medicine
- Tics/Tourettes syndrome (TS)
- Published paper
![]()
‘What's in a Name?’ Naming Genetically Determined Movement Disorders: Gap and Controversy
November 2025- Genetics
- Published paper
![]()
Clinical and Radiological Evolution of Idiopathic Normal Pressure Hydrocephalus: A Critical Review
November 2025- Biomarkers & Diagnostic Tools
- Other Movement Disorders
- Gait & Balance Disorders
- Published paper
![]()
Assessing Digital Health Technologies for Outcome Measurement in Parkinson's Disease Drug Trials: A Systematic Review
November 2025- Biomarkers & Diagnostic Tools
- Therapies-Pharmacological
- Clinical Trials
- Published paper
![]()
Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs
October 2025- Biomarkers & Diagnostic Tools
- Parkinson Disease/Hypokinetic Movement Disorders
- Rating Scales
- Published paper
![]()
Longitudinal Evaluation of an Abbreviated Patient-Reported Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) for Predicting Dopaminergic Therapy Initiation in Early Parkinson's Disease
October 2025- Biomarkers & Diagnostic Tools
- Therapies-Pharmacological
- Dopaminergic medications
- Rating Scales
- Published paper
![]()
RAB32-Linked Parkinson's Disease: Deep Phenotyping, MDSGene Literature Review, and Application of SynNeurGe Criteria
October 2025- Etiology & Pathophysiology
- Non-motor Symptoms/Disorders
- Genetics
- Published paper
![]()
A Holistic Wellness Prescription for Parkinson's Disease: Evidence-Based Perspectives and Unmet Needs
October 2025- Therapies-Other
- Published paper
![]()
Current Perspectives and Practices in Infection-Related Movement Disorders (IRMD): Insights from a Survey of Members of the International Parkinson and Movement Disorder Society
September 2025- Biomarkers & Diagnostic Tools
- Etiology & Pathophysiology
- Environmental Risk factors
- Neuroimaging
- Published paper
![]()
Progressive Supranuclear Palsy—A Global Review
September 2025- Epidemiology & Environment
- Parkinson Disease/Hypokinetic Movement Disorders
- Epidemiology
- Progressive Supranuclear Palsy (PSP)
- Published paper
![]()
The Management of Parkinson's Disease Before, During and After Pregnancy — an MDS Scientific Issues Committee Review
August 2025- Care Models
- Parkinson Disease/Hypokinetic Movement Disorders
- Primary Care
- Published paper




